Real-time enrollment status for this cystic fibrosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:08 PM UTC
| NCT Number | NCT06016088 |
| Recruiting Status | Recruiting |
| Condition | Cystic Fibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 72 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Respirion Pharmaceuticals Pty Ltd |
| Last Updated on CT.gov | December 29, 2025 (Dec 29, 2025) |
As of March 2, 2026: Clinical trial NCT06016088 is currently recruiting participants. This clinical trial study for cystic fibrosis is actively seeking new participants at 12 locations across the United States. The study is sponsored by Respirion Pharmaceuticals Pty Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06016088 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06016088 was last updated Dec 29, 2025 (December 29, 2025). HelloStudys verifies this status automatically.